Profile data is unavailable for this security.
About the company
Inter Pharma Public Company Limited is a Thailand-based biopharmaceutical company. The Company is engaged in the import, manufacture and distribution of drug, dietary supplement products for humans and animals. Its segments include Human healthcare, Animal healthcare, and Hospital and clinics. It provides animal health care products and human health care products. It develops and delivers health products that use biotechnology for disease prevention, longevity, and anti-aging. Its human health care products include pharmaceuticals, nutraceuticals / health supplements, cosmeceuticals, functional foods and drinks and others. Its animal health care products include medicine companion animal, neutraceuticals companion animal, shampoo, vaccine and immunoglobulin, premium pet food, ear cleaner, teeth cleaner and pee pad. Its products include ProLivo, Pronac Mood, Probac 7 and others. It also offers pet food for dogs and cats. Its subsidiaries include Inter Vetta Co., Ltd., and among others.
- Revenue in THB (TTM)2.15bn
- Net income in THB112.01m
- Incorporated2019
- Employees162.00
- LocationInter Pharma PCL140/9 ITF Tower 9th FloorSilom Road, SuriyawongBANGKOK 10500ThailandTHA
- Phone+66 26340225
- Fax+66 26340135
- Websitehttps://www.interpharma.co.th/
Mergers & acquisitions
| Acquired company | IP:SET since announced | Transaction value |
|---|---|---|
| Interpharma-ZEAvita Co Ltd | 10.00% | -- |
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Polypid Ltd | 0.00 | -1.06bn | 2.59bn | 57.00 | -- | 4.97 | -- | -- | -2.98 | -2.98 | 0.00 | 0.9237 | 0.00 | -- | -- | 0.00 | -147.37 | -90.05 | -241.51 | -109.86 | -- | -- | -- | -- | -- | -22.38 | 0.1359 | -- | -- | -- | -21.61 | -- | -38.71 | -- |
| Vetnostrum Animal Health Co Ltd | 1.35bn | 118.15m | 2.60bn | 185.00 | 20.75 | 2.01 | 13.53 | 1.92 | 1.74 | 1.74 | 19.77 | 17.95 | 0.9165 | 2.78 | 6.48 | 7,399,816.00 | 8.00 | 7.64 | 9.81 | 10.10 | 31.85 | 31.00 | 8.73 | 9.19 | 2.18 | 73.65 | 0.0174 | 49.57 | 7.17 | 3.68 | 49.15 | 3.98 | -30.60 | -- |
| Fusen Pharmaceutical Co Ltd | 1.08bn | -785.89m | 2.61bn | 1.05k | -- | 1.68 | -- | 2.41 | -0.2677 | -0.2677 | 0.3687 | 0.5301 | 0.1875 | 1.11 | 4.05 | 240,982.60 | -13.62 | -2.83 | -32.04 | -5.40 | 41.39 | 51.61 | -72.61 | -8.00 | 0.4241 | -0.4344 | 0.5137 | -- | -42.36 | -4.36 | -420.39 | -- | -17.55 | -- |
| Merck Tbk PT | 2.03bn | 329.52m | 2.65bn | 369.00 | 8.03 | 1.72 | 6.46 | 1.31 | 398.45 | 398.45 | 2,448.93 | 1,859.85 | 1.15 | 1.74 | 6.55 | 2,917,872,000.00 | 18.74 | 14.65 | 21.71 | 18.93 | 40.15 | 39.72 | 16.27 | 14.77 | 3.79 | -- | 0.0179 | 73.42 | 7.83 | 6.84 | -13.90 | 14.42 | -10.51 | 5.51 |
| Accent Microcell Ltd | 952.50m | 118.81m | 2.69bn | 192.00 | 21.45 | 3.14 | 20.15 | 2.82 | 15.24 | 15.24 | 122.20 | 104.07 | 1.12 | 4.14 | 5.32 | 14,474,330.00 | 13.99 | -- | 15.95 | -- | 39.96 | -- | 12.47 | -- | 3.01 | 76.48 | 0.0046 | -- | 7.77 | -- | 9.60 | -- | -- | -- |
| Inter Pharma PCL | 2.15bn | 112.01m | 2.69bn | 162.00 | 23.99 | 1.32 | 11.21 | 1.25 | 0.185 | 0.185 | 3.56 | 3.36 | 0.6962 | 3.64 | 6.89 | 13,293,500.00 | 4.00 | 3.98 | 5.34 | 5.19 | 40.52 | 40.40 | 5.75 | 6.01 | 1.23 | 7.92 | 0.1549 | 23.26 | 6.52 | 38.23 | -26.60 | -3.03 | 160.41 | -- |
| Cinclus Pharma Holding publ AB | 168.31m | -615.43m | 2.70bn | 19.00 | -- | 1.84 | -- | 16.03 | -3.80 | -3.80 | 1.04 | 9.07 | 0.0777 | -- | 15.47 | 3,724,539.00 | -28.43 | -- | -32.01 | -- | -- | -- | -365.65 | -- | -- | -- | 0.0197 | -- | -23.14 | -- | 21.89 | -- | -- | -- |
| Uni-Bio Science Group Ltd | 2.34bn | 362.77m | 2.70bn | 504.00 | 7.48 | 1.78 | 5.95 | 1.15 | 0.0152 | 0.0152 | 0.0976 | 0.0641 | 1.13 | 3.62 | 9.18 | 1,210,657.00 | 17.51 | 6.21 | 22.17 | 8.56 | 82.19 | 80.72 | 15.49 | 4.96 | 3.22 | 59.39 | 0.22 | 1,633.58 | 14.08 | 21.43 | 16.79 | 102.04 | 32.65 | -- |
| Verrica Pharmaceuticals Inc | 956.93m | -807.47m | 2.76bn | 71.00 | -- | -- | -- | 2.88 | -3.44 | -3.44 | 3.50 | -1.80 | 0.8352 | 1.09 | 8.75 | 434,211.30 | -70.48 | -71.91 | -217.79 | -111.91 | 91.36 | -- | -84.38 | -729.00 | 1.18 | -1.70 | 1.94 | -- | 47.66 | -- | -14.31 | -- | -47.58 | -- |
| Valerio Therapeutics SA | 67.43m | -485.23m | 2.80bn | 25.00 | -- | -- | -- | 41.48 | -0.0914 | -0.0914 | 0.012 | -0.0591 | 0.0735 | -- | 0.4026 | 48,157.89 | -52.95 | -33.39 | -145.21 | -42.47 | 59.34 | 78.97 | -720.27 | -631.62 | -- | -17.09 | -- | -- | -0.3889 | -16.01 | -17.57 | -- | 65.11 | -- |
